Saturday, May 23, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 23 '26)

 


    Ann Intern Med

  1. ALBALOUL H, Nemer A, Saini N, Schuster MG, et al
    Infectious Diseases: What You May Have Missed in 2025.
    Ann Intern Med. 2026 Apr 14:e2600983. doi: 10.7326/ANNALS-26-00983.
    PubMed         Abstract available

  2. REIS G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, et al
    The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
    Ann Intern Med. 2026 Mar 31. doi: 10.7326/ANNALS-25-03959.
    PubMed         Abstract available

  3. MILLER M, Fischer S, Azrael D
    Firearm Acquisition and New Exposure to Household Firearms After the Initial Pandemic Purchasing Surge: Results From the 2024 National Firearms Survey.
    Ann Intern Med. 2026;179:637-644.
    PubMed         Abstract available

  4. QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
    Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05485.
    PubMed         Abstract available

  5. MOSER ITK, Dobrescu AI, Sommer I, Goeschl S, et al
    Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05536.
    PubMed         Abstract available

  6. QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
    COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
    Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
    PubMed         Abstract available

  7. DOBRESCU A, Pinte L, Sharifan A, Gadinger A, et al
    Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05044.
    PubMed         Abstract available


    Antiviral Res

  8. PAGLIARI M, Lutken C, Vianello L, Mazzacan E, et al
    LTX-109 as a broad-spectrum antiviral: in vitro and in vivo efficacy against SARS-CoV-2 and Influenza Viruses.
    Antiviral Res. 2026 May 19:106444. doi: 10.1016/j.antiviral.2026.106444.
    PubMed         Abstract available

  9. WANG W, Yang F, Liu K, Cai M, et al
    A mouse model of human-derived H10N3 influenza enables preclinical evaluation of antiviral efficacy.
    Antiviral Res. 2026 May 18:106436. doi: 10.1016/j.antiviral.2026.106436.
    PubMed         Abstract available


    J Gen Virol

  10. SASVARI H, Sherry L, Logan N, Dunbar D, et al
    Serological response to feline coronavirus in the UK domestic cat population.
    J Gen Virol. 2026;107:002270.
    PubMed         Abstract available


    J Immunol

  11. SAIDU A, Crawford JC, Walden S, Qu JH, et al
    Highly focused human CD8+ T-cell response in the lower airways during acute influenza infection.
    J Immunol. 2026;215:vkag068.
    PubMed         Abstract available


    J Infect

  12. SMITH CS, Mohmand Z, Hrycyshyn A, Djerboua M, et al
    Risk of severe influenza in people with a history of injection drug use in Ontario: A population-based nested case control study.
    J Infect. 2026 May 20:106764. doi: 10.1016/j.jinf.2026.106764.
    PubMed         Abstract available


    J Virol

  13. BAYUROVA E, Kostyushev D, Tikhonov A, Chulanov V, et al
    Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.
    J Virol. 2026 Mar 23:e0007726. doi: 10.1128/jvi.00077.
    PubMed         Abstract available

  14. POZHIDAEVA A, Hoch JC, Pustovalova Y
    The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family.
    J Virol. 2026 Apr 3:e0203825. doi: 10.1128/jvi.02038.
    PubMed         Abstract available

  15. RAHEJA H, Sahu R, Ghosh T, Paul S, et al
    HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.
    J Virol. 2026 Apr 16:e0027626. doi: 10.1128/jvi.00276.
    PubMed         Abstract available

  16. SALISCH F, Muller-Ruttloff C
    Behind the membranous curtain-lipid dynamics and functions in coronaviral replication.
    J Virol. 2026 Apr 21:e0175325. doi: 10.1128/jvi.01753.
    PubMed         Abstract available

  17. GUO D, Yu S, Ma K, Tao H, et al
    Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity.
    J Virol. 2026 Apr 27:e0167925. doi: 10.1128/jvi.01679.
    PubMed         Abstract available

  18. NASIR A, Lee D, Avena LE, Berrueta DM, et al
    Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.
    J Virol. 2026 Apr 27:e0022526. doi: 10.1128/jvi.00225.
    PubMed         Abstract available

  19. CHEN L, Su H, Shang W, Nie T, et al
    SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.
    J Virol. 2026 Apr 27:e0222325. doi: 10.1128/jvi.02223.
    PubMed         Abstract available

  20. KOTANI N, Iwasa K, Amimoto T, Yamashita C, et al
    Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment.
    J Virol. 2026 Apr 29:e0050726. doi: 10.1128/jvi.00507.
    PubMed         Abstract available


    PLoS Comput Biol

  21. KLOCHKOV KA, Kozlov IE, Ilina EN, Manolov AI, et al
    Human mobility and outbreak origins in epidemic spread: Insights from agent-based modeling.
    PLoS Comput Biol. 2026;22:e1014279.
    PubMed         Abstract available


    PLoS One

  22. EL KHATIB Y, Mukhamedova F
    An alternative strategy for balancing profit maximization and risk reduction.
    PLoS One. 2026;21:e0348577.
    PubMed         Abstract available

  23. LINDAHL YL, Noren H, Engstrom AH, Grandahl M, et al
    A solo journey in the shadow of a double-edged pandemic: A qualitative study of women's experience of being pregnant during the COVID-19 pandemic.
    PLoS One. 2026;21:e0349378.
    PubMed         Abstract available

  24. RAUT B, Palla G, Wang J, Campbell S, et al
    ThermiQuant AquaStream: A portable instrument for quantitative colorimetric isothermal nucleic acid amplification reactions in paper and tube formats.
    PLoS One. 2026;21:e0348607.
    PubMed         Abstract available

  25. VISKUPIC F, Daly R, Wiltse DL, Gonda M, et al
    The relationship between personal COVID-19 vaccination decisions and cattle vaccination practices: Evidence from a survey of South Dakota beef producers.
    PLoS One. 2026;21:e0349234.
    PubMed         Abstract available

  26. LENARZ AM, Park H, Roberts MT, Pan A, et al
    The impact of COVID-19 on longevity trends and disparities among Native Americans and Whites in the Four Corners States.
    PLoS One. 2026;21:e0347924.
    PubMed         Abstract available

  27. WILLIAMS H, Armstrong M, Alexander R, Groner J, et al
    Dual pandemic of firearm injury and COVID-19 in Central and Southeastern Ohio: An interrupted time series analysis.
    PLoS One. 2026;21:e0335813.
    PubMed         Abstract available

  28. GONGORA-BENDEZU JA, Martinez-Lopez MV, Aguinaga-Fernandez AD, Yovera-Aldana M, et al
    Post-COVID spirometric abnormalities in workers with intermittent high-altitude exposure: A cross-sectional study in Peru.
    PLoS One. 2026;21:e0329054.
    PubMed         Abstract available

  29. RIOS MONTOYA V, Suarez Alarcon AY, Perez Castillo S, Zamudio Raez T, et al
    Beyond coverage: Can vaccination reduce child mortality despite structural inequality? A global ecological analysis of routine childhood immunization (2010-2023).
    PLoS One. 2026;21:e0340756.
    PubMed         Abstract available

  30. KOO H, Morrow CD
    Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19.
    PLoS One. 2026;21:e0349350.
    PubMed         Abstract available

  31. SHOJI M, Nakaoka K, Ishikawa M, Kasai Y, et al
    Correction: Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase.
    PLoS One. 2026;21:e0349522.
    PubMed         Abstract available

  32. LIN J, Chen J, Wan L, He W, et al
    Computational models for the classification of antibody specificity using heavy chain features.
    PLoS One. 2026;21:e0349143.
    PubMed         Abstract available

  33. DENG Y, Tang Z, Chen Q, Hu X, et al
    Computational biology exposed a common pathogenic mechanism in influenza A and Guillain-Barre syndrome.
    PLoS One. 2026;21:e0349687.
    PubMed         Abstract available

  34. ARINAITWE J, Bakamutumaho B, Mugenyi L, Kiwanuka N, et al
    The epidemiology of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus circulation among adult patients with acute respiratory illness in Kampala Metropolitan Area in Uganda.
    PLoS One. 2026;21:e0344869.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A


  35. Correction for Corell-Escuin et al., Dermcidin has antiviral activity and protects against influenza.
    Proc Natl Acad Sci U S A. 2026;123:e2613956123.
    PubMed        

  36. OZA AN, O'Brien KM, Gleeson JP
    Detecting changepoints in dynamical systems: Modeling time-varying transmission of seasonal influenza.
    Proc Natl Acad Sci U S A. 2026;123:e2533861123.
    PubMed         Abstract available


    Vaccine

  37. TANG YS, Chen C, Lv H, Sun Y, et al
    Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.
    Vaccine. 2026;83:128634.
    PubMed         Abstract available

  38. UKAH UV, Haapala JL, Benitez GV, DeSilva MB, et al
    Language and racial disparities in COVID-19 vaccination during pregnancy and lactation.
    Vaccine. 2026;83:128638.
    PubMed         Abstract available

  39. PAUL KK, Torres M, Shih STF, Gray RT, et al
    Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.
    Vaccine. 2026;83:128644.
    PubMed         Abstract available

  40. TUITE AR, Forbes N, Salvadori MI, Tunis M, et al
    Cost-effectiveness of ongoing COVID-19 vaccination in the context of high population immunity: A structured review of international economic evidence.
    Vaccine. 2026;83:128660.
    PubMed         Abstract available

  41. HARMA V, Palsola M, Kuusipalo A, Lindh E, et al
    Lessons from the 2024 avian influenza vaccination campaign in Finland: a qualitative inquiry.
    Vaccine. 2026;86:128736.
    PubMed         Abstract available

  42. RANQUE B, Galtier F, Nunes H, Le Jeunne C, et al
    Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study.
    Vaccine. 2026;86:128732.
    PubMed         Abstract available

No comments:

Post a Comment

My New Space

Most Popular Posts